Company intelligence / Profile preview

Reevemark

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Reevemark has significant experience with high-profile crises, litigation PR, and communications for regulated industries (including healthcare and biotech clients such as 23andMe), but it does not conduct drug development or clinical trials[1][4][5].

Industry: Consulting

Partnerships

Notable client relationships include engagements with 23andMe and Forever 21 for crisis communications, particularly in bankruptcy and restructuring contexts[4].

Beyond the preview

Go deeper on Reevemark.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reevemark.

Explore the full profile